Archive | CIHR RSS for this section

Cannabis Research in Priority Areas Team Grants

The Canadian Institutes of Health Research Institute of Cancer Research (ICR) and Institute of Neurosciences, Mental Health and Addiction (INMHA), in partnership with the Canadian Cancer Society, will support Research investigating the benefits and/or harms related to therapeutic use of cannabis in people living with cancer.

See CIHR grant page HERE

The Cannabis Research in Priority Areas Team Grants is expected to:

  • •Generate new scientific knowledge that will advance our understanding of the potential benefits and/or harms of cannabis and/or cannabis use, and impact policies and programs in this area
  • Encourage interdisciplinary collaborations, including from across health research and from domains outside of health research, and the sharing of data and resources
  • Enhancing capacity development and training in cannabis research
  • Connect to existing knowledge translation efforts across Canada, for example through MHCC or the Canadian Centre on Substance Use and Addiction (CCSA)

The maximum amount per grant is $300,000 per year for up to 5 years for a total of $1.5 million, per grant. $1.5 million is available to fund an application relevant to the Cancer Pool (sponsored by the Canadian Cancer Society, ICR, and INMHA).

LOI due date: May 15, 2019
LOI notice of decision: July 15, 2019
Full application deadline: October 8, 2019
Funding start date: January 1, 2020

All applications must be submitted through CIHR’s ResearchNet. For more information view the funding opportunity details on the CIHR website.

CIHR will be hosting webinar(s) to review with participants the requirements of this funding opportunity and to answer questions. To find out more information and to register, visit the Webinars page.

CCS/CIHR Cancer Survivorship Team Grants

www.cancer.ca/en/research/grants-and-awards/current-funding-opportunities/survivorship-team-grants/

The goal of the CCS/CIHR Cancer Survivorship Team Grant program is to improve the health outcomes for cancer survivors of all ages (pediatric, adolescent, young adult and adult) from the time of their cancer diagnosis until the time of their death or entry into palliative care. This program is not intended to focus on improving end-of-life care.

The intent of this funding opportunity is to support new intervention research designed to mitigate the challenges experienced along the survivorship journey, as well as the evaluation and validation of existing interventions to assess their potential for implementation as best practices.

The program goal will be achieved through the support of a network of multidisciplinary teams, each led by a nominated Principal Investigator and at least 2 co-Principal and/or co- Investigators, one of whom must be within their first five years as an independent researcher, drawn from at least 3 different regions of Canada (Atlantic Provinces, Central Canada, Prairie Provinces, West Coast, Northern Territories). Survivors and caregivers are expected to be engaged as full and active members of research teams.

Teams may request up to $500,000 per year for a maximum of $2,500,000 over a five-year period. Grants will be non-renewable. As the total budget for this competition is $10 million, it is anticipated that at least 4 teams will be funded in this competition. The engagement of additional partners may increase this number.

Registration due date: May 29, 2019
Relevance review results: mid-June, 2019
Full application deadline: September 10, 2019
Results announcement : November 2019
Anticipated start date: December 1, 2019

All applications must be submitted through the online application system (EGrAMS) by 5p.m. EST on the deadline date. Submissions will not be accepted beyond these times.

A Webinar is planned to explain the application process and overall objectives of the call. Applicants can register by sending an email at research@cancer.ca. Details for the April 8th, 2019 (@1pm EST) webinar will be provided in advance to interested applicants.